Assistant Professor and Fellowship Director, Oncologic and Microvascular Reconstructive Surgery Boston University Boston, Massachusetts
This session will review immunology in oncology, current guidelines for immunotherapy in head and neck cancer and areas of active research on the horizon.
Learning Objectives:
At the conclusion of this presentation, participants should be able to:
Describe the cells and interactions involved with immuno-oncology.
Analyze differing checkpoint inhibitors used in treatment of head and neck cancer, when they are used, and their advantages and disadvantages.
Discuss new strategies for immunotherapy being investigated.